Uncategorized

Sanderson Says It’s Picked Up A New’ Significant’ Customer

-Bloomberg

byBenzinga Newsdesk

May 19, 2021

1 minute read

-Bloomberg

ThredUp Q4 EPS $(0.19) Beats $(0.20) Estimate, Sales $71.32M Beat $63.03M Estimate

By Michael Horton

March 6, 5:11 PM

ThredUp (NASDAQ:TDUP) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 5.56 percent decrease over losses of $(0.18) per share from the same

TDUP

Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today

By Benzinga Insights

March 14, 5:36 PM

GAINERS: Wellbeing Digital (OTC:KONEF) shares closed up 148.45% at $0.40 LOSERS:

ALID

News

Akero Therapeutics Presents at the American Diabetes Association’s 81st Scientific Sessions, Demonstrating that Improvements in Adipose Tissue Metabolism Contributed Substantially to Improved Liver Health and Better Glycemic Control in Efruxifermin (EF…

By Michael Horton

June 25, 11:32 AM

Akero Therapeutics, Inc. (NASDAQ:AKRO), a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH), today announced additional analyses from its

AKRO

Kimball Electronics Q1 Adj. EPS $0.06 May Not Compare To $0.43 Estimate, Sales $292.70M Miss $314.10M Estimate

By Bill Haddad

November 3, 4:10 PM

Kimball Electronics (NASDAQ:KE) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.43 by 86.05 percent. This is a 90.77 percent decrease over earnings of $0.65 per share from

Sanderson Says It’s Picked Up A New’ Significant’ Customer

Related Posts

ThredUp Q4 EPS $(0.19) Beats $(0.20) Estimate, Sales $71.32M Beat $63.03M Estimate

Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today

Akero Therapeutics Presents at the American Diabetes Association’s 81st Scientific Sessions, Demonstrating that Improvements in Adipose Tissue Metabolism Contributed Substantially to Improved Liver Health and Better Glycemic Control in Efruxifermin (EF…

Kimball Electronics Q1 Adj. EPS $0.06 May Not Compare To $0.43 Estimate, Sales $292.70M Miss $314.10M Estimate